Skip to Main Content

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)


Diseases of the Integumentary System

Phase II

What is the purpose of this trial?

Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata

  • Trial with
    AnaptysBio Inc.
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC